A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.

Okada M, Ogawa H, Takagi T, Nishihara E, Yoshida T, Hyodo J, Shinomori Y, Honda N, Fujiwara T, Teraoka M, Yamada H, Hirano SI, Hato N

Open source

DOI
10.3389/fnins.2022.1024634
Published
2022
Container
Frontiers in neuroscience
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnins.2022.1024634,
  title = {A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.},
  author = {Okada M and Ogawa H and Takagi T and Nishihara E and Yoshida T and Hyodo J and Shinomori Y and Honda N and Fujiwara T and Teraoka M and Yamada H and Hirano SI and Hato N},
  year = {2022},
  journal = {Frontiers in neuroscience},
  doi = {10.3389/fnins.2022.1024634},
  url = {https://doi.org/10.3389/fnins.2022.1024634}
}

RIS

TY  - JOUR
TI  - A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.
AU  - Okada M
AU  - Ogawa H
AU  - Takagi T
AU  - Nishihara E
AU  - Yoshida T
AU  - Hyodo J
AU  - Shinomori Y
AU  - Honda N
AU  - Fujiwara T
AU  - Teraoka M
AU  - Yamada H
AU  - Hirano SI
AU  - Hato N
PY  - 2022
JO  - Frontiers in neuroscience
DO  - 10.3389/fnins.2022.1024634
UR  - https://doi.org/10.3389/fnins.2022.1024634
ER  - 

APA

M, O., H, O., T, T., E, N., T, Y., J, H., Y, S., N, H., T, F., M, T., H, Y., SI, H., & N, H. (2022). A double-blinded, randomized controlled clinical trial of hydrogen inhalation therapy for idiopathic sudden sensorineural hearing loss.. Frontiers in neuroscience. https://doi.org/10.3389/fnins.2022.1024634

Source records